McKesson (MCK) Getting Somewhat Favorable Media Coverage, Accern Reports

Media headlines about McKesson (NYSE:MCK) have been trending somewhat positive on Saturday, according to Accern. Accern ranks the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. McKesson earned a daily sentiment score of 0.18 on Accern’s scale. Accern also gave media stories about the company an impact score of 45.3975409672631 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Here are some of the news articles that may have impacted Accern Sentiment Analysis’s analysis:

How to Become a New Pot Stock Millionaire

Several equities analysts recently issued reports on the company. Needham & Company LLC upped their price objective on McKesson from $173.00 to $180.00 and gave the company a “buy” rating in a research report on Tuesday, January 23rd. Robert W. Baird reaffirmed a “buy” rating and issued a $200.00 price objective on shares of McKesson in a research report on Wednesday, January 17th. Mizuho set a $186.00 target price on shares of McKesson and gave the company a “hold” rating in a research note on Wednesday, January 24th. Jefferies Group upgraded shares of McKesson from a “hold” rating to a “buy” rating and set a $205.00 target price for the company in a research note on Wednesday, January 24th. Finally, Credit Suisse Group reiterated a “sell” rating and set a $130.00 target price on shares of McKesson in a research note on Friday, February 2nd. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and nine have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $176.32.

Shares of NYSE:MCK traded down $0.85 during midday trading on Friday, hitting $146.25. The company had a trading volume of 1,007,796 shares, compared to its average volume of 1,584,413. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.07 and a quick ratio of 0.61. The firm has a market capitalization of $30,352.51, a price-to-earnings ratio of 12.60, a price-to-earnings-growth ratio of 1.35 and a beta of 1.32. McKesson has a 12-month low of $133.82 and a 12-month high of $178.86.

McKesson (NYSE:MCK) last posted its quarterly earnings data on Thursday, February 1st. The company reported $3.41 EPS for the quarter, topping the consensus estimate of $2.92 by $0.49. The firm had revenue of $53.62 billion during the quarter, compared to analyst estimates of $51.98 billion. McKesson had a return on equity of 22.98% and a net margin of 2.34%. McKesson’s revenue was up 7.0% on a year-over-year basis. During the same period in the prior year, the business posted $3.04 EPS. equities research analysts expect that McKesson will post 12.69 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Monday, April 2nd. Stockholders of record on Thursday, March 1st were paid a $0.34 dividend. The ex-dividend date of this dividend was Wednesday, February 28th. This represents a $1.36 annualized dividend and a dividend yield of 0.93%. McKesson’s dividend payout ratio (DPR) is 11.71%.

In other news, SVP Erin M. Lampert sold 1,413 shares of the company’s stock in a transaction on Thursday, March 1st. The stock was sold at an average price of $149.38, for a total value of $211,073.94. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 1.20% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “McKesson (MCK) Getting Somewhat Favorable Media Coverage, Accern Reports” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright laws. The correct version of this piece can be accessed at

McKesson Company Profile

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.

Insider Buying and Selling by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with's FREE daily email newsletter.

Leave a Reply